OFIX logo

ORTHOFIX MEDICAL INC

OFIXNASDAQ
πŸ† #3143 by market capEarnings Nov 2US Equity
$9.75β–Ό $0.09 (βˆ’0.91%)
πŸŒ™ After hours$9.75β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track OFIX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.9%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$394M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+3.0%
Slowing
πŸ“ŠGross Margin
71.3%
High
πŸ’΅FCF Margin
2.9%
Thin
βš–οΈP/S Ratio
0.5x
Cheap
Otter Score
76
Good
No chart data available for OFIX.

Trading Snapshot

Day Range
$9.68 – $9.92
52-Week Range
$8.50 – $16.99
Volume
$2.02B
Avg Volume
$2.55B
Shares Outstanding
40.4M
Next Earnings
Nov 21, 2026

Fundamentals Snapshot

Annual Revenue
$822M
Last Q Revenue
$211M
P/E Ratio
β€”
P/S Ratio
0.5x
EPS (TTM)
$-1.53
Dividend Yield
β€”
Dilution (1yr)
+3.4%

Why Investors Own OFIX

  • βœ“High-growth profile β€” revenue up +1.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 61% gross margin and 14% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

OFIX logo

ORTHOFIX MEDICAL INC

OFIX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$822Mβ–² +2.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
67.1%β–Ό βˆ’1.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$68Mβ–Ό βˆ’19.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$1Mβ–Ό βˆ’85.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
40.0Mβ–² +3.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$147Mβ–Ό βˆ’$51M YoY
StockOtter Β· stockotter.space

About ORTHOFIX MEDICAL INC

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$10.84
β–² +11.2% Upside
High Target$13.38
Low Target$9.66
Based on 12 analysts

Latest News & Updates

MarketBeatΒ·Aug 15

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook

Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected Europe

MarketBeatΒ·Aug 5

Orthofix Medical Q2 Earnings Call Highlights

Orthofix Medical NASDAQ: OFIX reported second-quarter results that management said reflected improving operating trends across several businesses, while continued weakness among smaller U.S. spine distributors remained a

Seeking AlphaΒ·Aug 5

Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript

Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript

Zacks Investment ResearchΒ·Aug 5

Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Zacks Investment ResearchΒ·Aug 5

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

Orthofix (OFIX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.13 per share a year ago.

Business WireΒ·Aug 5

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress t